Abstract
We report here the synthesis of substituted 4‐chloro‐N‐[3‐oxo‐3‐(4‐aryl‐1‐piperazinyl)‐propyl] benzamides (5–9), as potential new antidepressants, incorporating in a single molecule structural moieties related to a dual pharmacological profile: MAO‐A inhibitor and 5‐HT1A receptor affinity.
Acknowledgments
This work was supported by the Research Project CEPEDEQ‐ FACULTAD of the Chemical and Pharmaceutical Sciences Faculty, University of Chile, Santiago, Chile, and FONDECYT 1030916.